CollPlant Biotechnologies (CLGN) Gross Margin (2017 - 2025)
CollPlant Biotechnologies (CLGN) reported Gross Margin of 220.0% for Q4 2025, down 15415.0% on a YoY basis from N/an in Q4 2024, and up 11.77% quarter-over-quarter from 249.35% in Q3 2025.
CollPlant Biotechnologies (CLGN) Gross Margin (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Gross Margin for 9 years, with the latest figure at 220.0% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin fell 15415.0% year-over-year to 220.0%; the trailing twelve-month figure through Dec 2025 stood at 295169.0% (down 29495347.0% YoY), and the FY2025 full-year result was 64.78%, up 28032.0% from the prior year.
- Gross Margin for Q4 2025 stood at 220.0%, up from 249.35% in the prior quarter.
- The five-year high for Gross Margin was 93.96% in Q2 2023, with the low at 3910614.53% in Q2 2025.
- Historically, Gross Margin has averaged 281421.08% across 5 years, with a median of 76.77% in 2021.
- Annual changes were most pronounced in 2022 — Gross Margin soared 142842923 bps — and 2025, when it plunged 391049926 bps.
- CollPlant Biotechnologies' Gross Margin stood at 76.77% in 2021, then jumped by 91 bps to 6.9% in 2022, then slumped by 2199 bps to 158.53% in 2023, then soared by 58 bps to 65.85% in 2024, then tumbled by 234 bps to 220.0% in 2025.
- The last three Gross Margin figures came in at 220.0% (Q4 2025), 249.35% (Q3 2025), and 3910614.53% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -220.00% |
| Sep 30, 2025 | -249.35% |
| Jun 30, 2025 | -3,910,614.53% |
| Mar 31, 2025 | 90.85% |
| Dec 31, 2024 | -65.85% |
| Sep 30, 2024 | -6,700.00% |
| Jun 30, 2024 | -115.26% |
| Mar 31, 2024 | -456.12% |
| Dec 31, 2023 | -158.53% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 93.96% |
| Mar 31, 2023 | 24.94% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | -142.20% |
| Jun 30, 2022 | 34.85% |
| Dec 31, 2021 | -76.77% |
| Sep 30, 2021 | -1,428,571.43% |
| Jun 30, 2021 | 37.92% |
| Mar 31, 2021 | 93.89% |
| Dec 31, 2020 | 51.08% |